Erlotinib exerts its unique therapeutic effect in blocking downstream signal transduction, reducing the activity of tyrosine kinase and the adhesion of tumor cells, and promoting tumor cell apoptosis by binding to epidermal growth factor receptors.18 Epidermal factor receptors may lead to tumor cell invasion, proliferation and metastasis. This evidence concerns the gene EGFR and neoplasm.